UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pathogenesis of Mantle-Cell Lymphoma: All Oncogenic Roads Lead to Dysregulation of Cell Cycle and DNA Damage Response Pathways

Journal of clinical oncology, 2005-09, Vol.23 (26), p.6364-6369

2005

Volltextzugriff (PDF)

Changes in adjuvant endocrine therapy over one year among postmenopausal women with early-stage breast cancer initiating aromatase inhibitors

Journal of clinical oncology, 2012-12, Vol.30 (34_suppl), p.11-11

2012

Volltextzugriff (PDF)

Efficacy of Contralateral Prophylactic Mastectomy in Women With a Personal and Family History of Breast Cancer

Journal of clinical oncology, 2001-10, Vol.19 (19), p.3938-3943

2001

Volltextzugriff (PDF)

Salvage Treatment With Paclitaxel, Ifosfamide, and Cisplatin Plus High-Dose Carboplatin, Etoposide, and Thiotepa Followed by Autologous Stem-Cell Rescue in Patients With Relapsed or Refractory Germ Cell Cancer

Journal of clinical oncology, 2001-01, Vol.19 (1), p.81-88

2001

Volltextzugriff (PDF)

Long-Term Results of First-Line Sequential High-Dose Etoposide, Ifosfamide, and Cisplatin Chemotherapy Plus Autologous Stem Cell Support for Patients With Advanced Metastatic Germ Cell Cancer: An Extended Phase I/II Study of the German Testicular Cancer Study Group

Journal of clinical oncology, 2003-11, Vol.21 (22), p.4083-4091

2003

Volltextzugriff (PDF)

Satisfaction After Contralateral Prophylactic Mastectomy: The Significance of Mastectomy Type, Reconstructive Complications, and Body Appearance

Journal of clinical oncology, 2005-11, Vol.23 (31), p.7849-7856

2005

Volltextzugriff (PDF)

High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008

Journal of clinical oncology, 2018-11, Vol.36 (31), p.JCO2018782516-3119

2018

Volltextzugriff (PDF)

Risk Factors for Relapse in Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: Results of the German Testicular Cancer Study Group Trial

Journal of clinical oncology, 2003-04, Vol.21 (8), p.1505-1512

2003

Volltextzugriff (PDF)

NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer

Journal of clinical oncology, 2024-07, Vol.42 (20), p.2446-2455

2024

Volltextzugriff (PDF)

International Prognostic Score for Nodular Lymphocyte–Predominant Hodgkin Lymphoma

Journal of clinical oncology, 2024-07, Vol.42 (19), p.2271-2280

2024

Volltextzugriff (PDF)

T-Cell Immunity to the Folate Receptor Alpha Is Prevalent in Women With Breast or Ovarian Cancer

Journal of clinical oncology, 2006-09, Vol.24 (26), p.4254-4261

2006

Volltextzugriff (PDF)

Spatial immunophenotypes of distant metastases and response to immune checkpoint inhibition

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.538-538

2023

Volltextzugriff (PDF)

Role of Genetic and Nongenetic Factors for Fluorouracil Treatment-Related Severe Toxicity: A Prospective Clinical Trial by the German 5-FU Toxicity Study Group

Journal of clinical oncology, 2008-05, Vol.26 (13), p.2131-2138

2008

Volltextzugriff (PDF)

Validation of the Immunoscore (IM) as a prognostic marker in stage I/II/III colon cancer: Results of a worldwide consortium-based analysis of 1,336 patients

JOURNAL OF CLINICAL ONCOLOGY, 2016-05, Vol.34 (15_suppl), p.3500-3500

2016

Volltextzugriff (PDF)

Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy

Journal of clinical oncology, 2010-11, Vol.28 (33), p.4906-4911

2010

Volltextzugriff (PDF)

Single Versus Sequential High-Dose Chemotherapy in Patients With Relapsed or Refractory Germ Cell Tumors: A Prospective Randomized Multicenter Trial of the German Testicular Cancer Study Group

Journal of clinical oncology, 2007-07, Vol.25 (19), p.2778-2784

2007

Volltextzugriff (PDF)

Progression-Free Survival in Children With Optic Pathway Tumors: Dependence on Age and the Quality of the Response to Chemotherapy—Results of the First French Prospective Study for the French Society of Pediatric Oncology

Journal of clinical oncology, 2003-12, Vol.21 (24), p.4572-4578

2003

Volltextzugriff (PDF)

Predictive value of fibroblast growth factor receptor (FGFR) alterations on anti-PD-(L)1 treatment outcomes in patients (Pts) with advanced urothelial cancer (UC): Pooled analysis of real-world data

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.493-493

2020

Volltextzugriff (PDF)

Temozolomide chemotherapy versus radiotherapy in molecularly characterized (1p loss) low-grade glioma: A randomized phase III intergroup study by the EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.2007-2007

2013

Volltextzugriff (PDF)

A phase I trial of veliparib, an inhibitor of poly(ADP-ribose) polymerase (PARP), and topotecan (TPT) in patients with solid tumors

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.TPS2618-TPS2618

2015

Volltextzugriff (PDF)

Radiotherapy in relation to temozolomide: Subgroup analysis of molecular markers of the randomized phase III study by the EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033) in patients with a high risk low-grade glioma

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.2006-2006

2015

Volltextzugriff (PDF)

Final results of APG101_CD_002: APG101 plus reirradiation versus reirradiation in the treatment of patients with progressive glioblastoma

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.2006-2006

2014

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Aktive Filter

ThemaPhysical Sciences

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(78)

Sprache

Englisch
(78)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(25)
Oncology
(25)
Science & Technology
(25)
Humans
(24)
Male
(17)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Female
(14)
Adult
(11)
Middle Aged
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)
Adolescent
(9)
Prognosis
(9)
Combined Modality Therapy
(8)
Infant
(8)
Tumors
(8)
Aged
(7)
Child
(7)
Child, Preschool
(7)
Disease-Free Survival
(7)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

J. Clin. Oncol
(1)

Menü

Weitere Dienste

Einstellungen

Pathogenesis of Mantle-Cell Lymphoma: All Oncogenic Roads Lead to Dysregulation of Cell Cycle and DNA Damage Response Pathways

Changes in adjuvant endocrine therapy over one year among postmenopausal women with early-stage breast cancer initiating aromatase inhibitors

Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network

Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group

Efficacy of Contralateral Prophylactic Mastectomy in Women With a Personal and Family History of Breast Cancer

Salvage Treatment With Paclitaxel, Ifosfamide, and Cisplatin Plus High-Dose Carboplatin, Etoposide, and Thiotepa Followed by Autologous Stem-Cell Rescue in Patients With Relapsed or Refractory Germ Cell Cancer

Long-Term Results of First-Line Sequential High-Dose Etoposide, Ifosfamide, and Cisplatin Chemotherapy Plus Autologous Stem Cell Support for Patients With Advanced Metastatic Germ Cell Cancer: An Extended Phase I/II Study of the German Testicular Cancer Study Group

Satisfaction After Contralateral Prophylactic Mastectomy: The Significance of Mastectomy Type, Reconstructive Complications, and Body Appearance

High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008

Risk Factors for Relapse in Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: Results of the German Testicular Cancer Study Group Trial

NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer

International Prognostic Score for Nodular Lymphocyte–Predominant Hodgkin Lymphoma

T-Cell Immunity to the Folate Receptor Alpha Is Prevalent in Women With Breast or Ovarian Cancer

Spatial immunophenotypes of distant metastases and response to immune checkpoint inhibition

Viable Malignant Cells After Primary Chemotherapy for Disseminated Nonseminomatous Germ Cell Tumors: Prognostic Factors and Role of Postsurgery Chemotherapy—Results From an International Study Group

Role of Genetic and Nongenetic Factors for Fluorouracil Treatment-Related Severe Toxicity: A Prospective Clinical Trial by the German 5-FU Toxicity Study Group

Validation of the Immunoscore (IM) as a prognostic marker in stage I/II/III colon cancer: Results of a worldwide consortium-based analysis of 1,336 patients

Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy

Single Versus Sequential High-Dose Chemotherapy in Patients With Relapsed or Refractory Germ Cell Tumors: A Prospective Randomized Multicenter Trial of the German Testicular Cancer Study Group

Progression-Free Survival in Children With Optic Pathway Tumors: Dependence on Age and the Quality of the Response to Chemotherapy—Results of the First French Prospective Study for the French Society of Pediatric Oncology

Predictive value of fibroblast growth factor receptor (FGFR) alterations on anti-PD-(L)1 treatment outcomes in patients (Pts) with advanced urothelial cancer (UC): Pooled analysis of real-world data

Temozolomide chemotherapy versus radiotherapy in molecularly characterized (1p loss) low-grade glioma: A randomized phase III intergroup study by the EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033)

A phase I trial of veliparib, an inhibitor of poly(ADP-ribose) polymerase (PARP), and topotecan (TPT) in patients with solid tumors

Radiotherapy in relation to temozolomide: Subgroup analysis of molecular markers of the randomized phase III study by the EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033) in patients with a high risk low-grade glioma

Final results of APG101_CD_002: APG101 plus reirradiation versus reirradiation in the treatment of patients with progressive glioblastoma

Aktive Filter

Suchergebnisse filtern